Effect of two oral contraceptives with different ethinyl estradiol and levonorgestrel concentrations on the urinary excretion of biochemical vasoactive markers

Contraception

Volumn 64, Issue 6, 2001, Pages 357-362

  Mueck, Alfred O ^a   Seeger, Harald ^a   Petersen, Gudula ^b   Schulte Wintrop, Ernst ^b   Wallwiener, Diethelm ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Wyeth Pharma GmbH   (Germany)

Author keywords

Contraceptive pills; Urinary excretion; Vasoactive markers

Indexed keywords

BIOCHEMICAL MARKER; CYCLIC GMP; ETHINYLESTRADIOL PLUS NORGESTREL; LEIOS; NATRIURETIC FACTOR; ORAL CONTRACEPTIVE AGENT; PROSTACYCLIN; SEROTONIN; THROMBOXANE; URODILATIN; VASOACTIVE AGENT;

ADULT; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROLYTE BALANCE; FEMALE; FLUID BALANCE; HOMEOSTASIS; HUMAN; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION;

ADULT; ANALYSIS OF VARIANCE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIOVASCULAR SYSTEM; CONTRACEPTIVES, ORAL, COMBINED; CYCLIC GMP; DOUBLE-BLIND METHOD; EPOPROSTENOL; ETHINYL ESTRADIOL; ETHINYL ESTRADIOL-NORGESTREL COMBINATION; FEMALE; HUMANS; KIDNEY; LEVONORGESTREL; PEPTIDE FRAGMENTS; SEROTONIN; THROMBOXANES; WATER-ELECTROLYTE BALANCE;

EID: 0035712422     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(01)00287-6     Document Type: Article

References (27)

1. Vascular aspects of oestrogen
2. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
3. The protective effects of estrogen on the cardiovascular system
4. Urinary prostanoids in postmenopausal women after transdermal and oral oestrogen
5. Is there any effect of estradiol on the vasodilating NO/cGMP-system? Investigations of the mechanism of cardiovascular protection by estrogen substitution in postmenopausal women
6. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women
7. Oral contraceptives and vascular reactivity of great vessels in women
8. Effect of sequential estrogen/progestin-treatment on biochemical vasoactive markers in postmenopausal women comparing oral and transdermal application
9. Urinary cGMP excretion after hormone replacement therapy in postmenopausal women
10. Influence of norethisterone acetate and estradiol on serotonin metabolism of postmenopausal women
11. The influence of norethisterone acetate on urinary urodilatin excretion in postmenopausal women
12. Application of an alpha-sidechain length-specific monoclonal antibody to immunoaffinity purification and enzyme immunoassay of 2,3-dinor-6-keto-prostaglandin F1 alpha from human urine
13. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats
14. Extracellular cyclic nucleotides
15. Alpha-human atrial natriuretic polypeptide-induced rise of plasma and urinary 3′5′-guanosine monophosphate concentration in human subjects
16. 17β-estradiol and endothelial nitric oxide synthase
17. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production
18. Effect of oral contraceptives on the urinary excretion of biochemical markers indicating vasoactive action
19. Natural and synthetic estrogens and prostacyclin production in human endothelial cells from umbilical cord and leg veins
20. 17alpha-ethinylestradiol decreases production and release of prostacyclin in cultured human umbilical vein endothelial cells
21. The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans
22. Effect of oral contraceptives containing 20 and 35 micrograms ethinyl estradiol on urinary prostacyclin and thromboxane metabolite levels in smokers and nonsmokers
23. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients
24. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina
25. Blood serotonin levels in postmenopausal women: Effects of age and serum oestradiol levels
26. The effect of estradiol on urodilatin production in postmenopausal women